Hologic Adopts Rights Plan as Icahn Reports 13% Stake

Hologic Inc., a maker of cervical cancer and breast biopsy tools, adopted a shareholder’s rights plan after billionaire investor Carl Icahn reported a 13 percent stake in the company and said he may seek board seats.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.